187 related articles for article (PubMed ID: 19188489)
21. Expression, subcellular localisation, and possible roles of dipeptidyl peptidase 9 (DPP9) in murine macrophages.
Zapletal E; Cupic B; Gabrilovac J
Cell Biochem Funct; 2017 Mar; 35(2):124-137. PubMed ID: 28256001
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidases in bovine reproductive organs and secretions.
Agrawal Y; Vanha-Perttula T
Int J Androl; 1986 Dec; 9(6):435-52. PubMed ID: 3570534
[TBL] [Abstract][Full Text] [Related]
23. Dipeptidyl peptidase 9 (DPP9) from bovine testes: identification and characterization as the short form by mass spectrometry.
Dubois V; Lambeir AM; Vandamme S; Matheeussen V; Guisez Y; Scharpé S; De Meester I
Biochim Biophys Acta; 2010 Apr; 1804(4):781-8. PubMed ID: 20026260
[TBL] [Abstract][Full Text] [Related]
24. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
Chen SJ; Jiaang WT
Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.
Brunetti M; Holth A; Panagopoulos I; Staff AC; Micci F; Davidson B
Virchows Arch; 2019 Feb; 474(2):177-185. PubMed ID: 30467600
[TBL] [Abstract][Full Text] [Related]
26. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.
Wang A; Dorso C; Kopcho L; Locke G; Langish R; Harstad E; Shipkova P; Marcinkeviciene J; Hamann L; Kirby MS
BMC Pharmacol; 2012 Apr; 12():2. PubMed ID: 22475049
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins.
Liu J; Huan Y; Li C; Liu M; Shen Z
Acta Pharm Sin B; 2014 Apr; 4(2):135-40. PubMed ID: 26579375
[TBL] [Abstract][Full Text] [Related]
28. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
29. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
30. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
[TBL] [Abstract][Full Text] [Related]
31. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
[TBL] [Abstract][Full Text] [Related]
32. Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.
Ross B; Krapp S; Augustin M; Kierfersauer R; Arciniega M; Geiss-Friedlander R; Huber R
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1437-E1445. PubMed ID: 29382749
[TBL] [Abstract][Full Text] [Related]
33. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
[TBL] [Abstract][Full Text] [Related]
34. Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.
Tang HK; Chen KC; Liou GG; Cheng SC; Chien CH; Tang HY; Huang LH; Chang HP; Chou CY; Chen X
FEBS Lett; 2011 Nov; 585(21):3409-14. PubMed ID: 22001206
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin.
Zhang H; Chen Y; Wadham C; McCaughan GW; Keane FM; Gorrell MD
Biochim Biophys Acta; 2015 Feb; 1853(2):470-80. PubMed ID: 25486458
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo.
Someya Y; Tahara A; Nakano R; Matsuyama-Yokono A; Nagase I; Fukunaga Y; Takasu T; Hayakawa M; Shibasaki M
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):209-17. PubMed ID: 18398600
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
Zhang H; Maqsudi S; Rainczuk A; Duffield N; Lawrence J; Keane FM; Justa-Schuch D; Geiss-Friedlander R; Gorrell MD; Stephens AN
FEBS J; 2015 Oct; 282(19):3737-57. PubMed ID: 26175140
[TBL] [Abstract][Full Text] [Related]
38. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Thornberry NA; Weber AE
Curr Top Med Chem; 2007; 7(6):557-68. PubMed ID: 17352677
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
